NCT03960385View on ClinicalTrials.gov

Assessing the Effectiveness of Sanofi Pasteur's Dengue Vaccine (Dengvaxia) Against Hospitalization and Symptomatic Infection in the State of Parana - Brazil

CompletedOBSERVATIONAL
Enrollment

1,854

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

March 1, 2020

Study Completion Date

March 1, 2020

Conditions
Dengue
Interventions
BIOLOGICAL

CYD-TDV

Dengue vaccine

Trial Locations (1)

Unknown

Augusto Leopoldo Ayrosa Galvão Study Center, São Paulo

All Listed Sponsors
collaborator

Pan American Health Organization

OTHER

collaborator

State of Parana/Health Department of Parana

UNKNOWN

collaborator

Ministry of Health, Brazil

OTHER_GOV

collaborator

Centro de Estudos Augusto Leopoldo Ayrosa Galvão

UNKNOWN

lead

Albert B. Sabin Vaccine Institute

OTHER

NCT03960385 - Assessing the Effectiveness of Sanofi Pasteur's Dengue Vaccine (Dengvaxia) Against Hospitalization and Symptomatic Infection in the State of Parana - Brazil | Biotech Hunter | Biotech Hunter